1. Home
  2. CPIX vs KORE Comparison

CPIX vs KORE Comparison

Compare CPIX & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • KORE
  • Stock Information
  • Founded
  • CPIX 1999
  • KORE 2003
  • Country
  • CPIX United States
  • KORE United States
  • Employees
  • CPIX N/A
  • KORE N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • KORE Telecommunications Equipment
  • Sector
  • CPIX Health Care
  • KORE Consumer Discretionary
  • Exchange
  • CPIX Nasdaq
  • KORE Nasdaq
  • Market Cap
  • CPIX 40.1M
  • KORE 39.3M
  • IPO Year
  • CPIX 2009
  • KORE N/A
  • Fundamental
  • Price
  • CPIX $3.52
  • KORE $2.50
  • Analyst Decision
  • CPIX
  • KORE Hold
  • Analyst Count
  • CPIX 0
  • KORE 2
  • Target Price
  • CPIX N/A
  • KORE $2.75
  • AVG Volume (30 Days)
  • CPIX 102.7K
  • KORE 17.8K
  • Earning Date
  • CPIX 08-05-2025
  • KORE 08-14-2025
  • Dividend Yield
  • CPIX N/A
  • KORE N/A
  • EPS Growth
  • CPIX N/A
  • KORE N/A
  • EPS
  • CPIX N/A
  • KORE N/A
  • Revenue
  • CPIX $41,083,299.00
  • KORE $282,254,000.00
  • Revenue This Year
  • CPIX N/A
  • KORE $4.66
  • Revenue Next Year
  • CPIX N/A
  • KORE $6.71
  • P/E Ratio
  • CPIX N/A
  • KORE N/A
  • Revenue Growth
  • CPIX 5.82
  • KORE N/A
  • 52 Week Low
  • CPIX $1.04
  • KORE $1.10
  • 52 Week High
  • CPIX $7.25
  • KORE $4.88
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 47.41
  • KORE 47.19
  • Support Level
  • CPIX $3.26
  • KORE $2.60
  • Resistance Level
  • CPIX $3.97
  • KORE $2.81
  • Average True Range (ATR)
  • CPIX 0.35
  • KORE 0.19
  • MACD
  • CPIX 0.09
  • KORE -0.00
  • Stochastic Oscillator
  • CPIX 53.09
  • KORE 33.08

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

Share on Social Networks: